Mesoblast Announces Changes to Board of Directors’ Leadership Roles
Mesoblast Announces Changes to Board of Directors' Leadership Roles GlobeNewswire January 01, 2026 NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual General Meeting the Board will undertake a number of changes in line […]